Previous close | 264.20 |
Open | 264.02 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 264.02 - 270.77 |
52-week range | 143.66 - 270.77 |
Volume | |
Avg. volume | 1,441 |
Market cap | 31.105B |
Beta (5Y monthly) | 0.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -7.49 |
Earnings date | 31 Oct 2024 - 04 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We recently compiled a list of the 10 Best Aggressive Growth Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against the other aggressive growth stocks. If you’re putting money in the stock market, it’s more likely than not that growth […]
As global markets grapple with economic slowdown concerns, the S&P 500 Index has experienced its steepest weekly decline in 18 months, driven by fears of a weakening U.S. labor market and seasonal trading patterns. Despite these challenges, certain stocks may present opportunities for investors seeking undervalued assets amidst the turbulence. In this environment, identifying undervalued stocks involves looking for companies with strong fundamentals that are temporarily out of favor or...
We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against the other biotech stocks. As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1,” the […]